Physician profile
Kenneth Koval
NPI 1144256041
$321,369.75
in general payments reported to CMS, 2019-2025
20 companies · $41K in 2025
The $41K reported for 2025 was more than what 90% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111K · 2020: $35K · 2021: $62K · 2022: $27K · 2023: $33K · 2024: $13K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $63K · Consulting Fee: $21K · Travel and Lodging: $1,949 · Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $62,958.73 |
| Consulting Fee | $21,394.19 |
| Travel and Lodging | $1,949.19 |
| Food and Beverage | $537.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $99,109.33 | 2019-2025 | Chimaera Hip Fracture System, Physio-Stim |
| Zimmer Biomet Holdings, INC. | $77,307.71 | 2019-2025 | Affixus |
| Acumed LLC | $68,825.41 | 2019-2022 | |
| Medshape, INC. | $25,091.65 | 2020-2021 | |
| Globus Medical, INC. | $19,158.82 | 2019-2025 | Anthem, Small Frag Plating System, Anthem Small Fragment |
| Advanced Orthopaedic Solutions, INC. | $16,281.65 | 2019-2020 | |
| Arthrex, INC. | $8,952.31 | 2021-2023 | |
| US Implant Solutions, LLC | $6,123.19 | 2023-2025 | |
| Organogenesis INC. | $148.23 | 2019 | |
| Depuy Synthes Sales INC. | $106.25 | 2019-2021 | |
| Smith+Nephew, INC. | $73.80 | 2019 | |
| Stryker Corporation | $33.51 | 2019 | |
| Polynovo North America LLC | $28.29 | 2024 | Novosorb Btm |
| Djo, LLC | $25.69 | 2019 | |
| Convatec INC. | $24.51 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $20.26 | 2019 | |
| Abbvie INC. | $18.39 | 2024 | |
| Kls-Martin L.P. | $15.16 | 2024 | |
| Integra Lifesciences Corporation | $13.54 | 2022 | |
| Si-Bone, INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Koval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.